Company Filing History:
Years Active: 1996-1998
Title: Sabah Abdel Jassim: Innovator in Antiviral and Antifungal Research
Introduction
Sabah Abdel Jassim is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antiviral and antifungal compositions. With a total of 3 patents to her name, her work has the potential to impact public health positively.
Latest Patents
Her latest patents include an antiviral or antifungal composition comprising an extract of pomegranate. Additionally, she has developed genetically engineered reporter bacteria for the detection of target bacteria. One of her innovative methods involves adding bacteriophage to a sample to infect the bacteria, killing extracellular bacteriophage without harming phage-infected bacteria. This process amplifies the remaining bacteriophage in the sample, allowing for the infection of reporter bacteria that produce an observable signal. The reporter bacteria are genetically engineered to express an indicator gene, which generates a detectable signal upon bacteriophage infection.
Career Highlights
Throughout her career, Sabah has worked with prominent companies such as Merck Patent GmbH and Amersham International Plc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Some of her notable coworkers include Stephen Paul Denyer and Gordon Sydney Stewart. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Sabah Abdel Jassim's contributions to antiviral and antifungal research through her patents and collaborations highlight her role as a significant innovator in biotechnology. Her work continues to pave the way for advancements in health-related technologies.